Lakewood Asset Management’s Pfizer PFE Stock Holding History

Lakewood Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,255	Closed	-$209K	–	117
2023 Q4	$209K	Sell	7,255 -8,867	-55%	-$268K	0.16%	102
2023 Q3	$535K	Sell	16,122 -2,730	-14%	-$96.5K	0.44%	60
2023 Q2	$692K	Sell	18,852 -560	-3%	-$21.8K	0.54%	53
2023 Q1	$792K	Buy	19,412 +1,921	+11%	+$83K	0.66%	46
2022 Q4	$896K	Buy	+17,491	New	+$839K	0.72%	43

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lakewood Asset Management's PFE Position: Q1 2024 in Review

Lakewood Asset Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 7,255 shares — an estimated $209K sold.

Lakewood Asset Management first reported a position in PFE in Q4 2022 and held it in 5 quarters. The position peaked at $896K in Q4 2022. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Lakewood Asset Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Lakewood Asset Management sold 7,255 Pfizer shares in Q1 2024, an estimated $209K.
Lakewood Asset Management first reported a position in Pfizer in Q4 2022 and held it in 5 quarters.
Lakewood Asset Management's Pfizer position peaked at $896K in Q4 2022.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Lakewood Asset Management's 13F filing for Q1 2024, filed 22 Apr 2024.